{
    "2021-04-09": [
        [
            {
                "time": "2023-04-08",
                "original_text": "毛利与净利双升！一个更具成长性的“CXO老二”？",
                "features": {
                    "keywords": [
                        "毛利",
                        "净利",
                        "成长性",
                        "CXO"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-04-08",
                "original_text": "【权益变动】药明康德(02359-HK)被Wellington Management减持59.1045万股 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "Wellington Management",
                        "减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-04-08",
                "original_text": "药明康德现5笔大宗交易 共成交5,887.91万元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "大宗交易"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-04-08",
                "original_text": "药明康德今日大宗交易成交42.18万股，成交价139.59元溢价0.0%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "大宗交易",
                        "溢价"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-04-08",
                "original_text": "Wellington Management Group LLP减持药明康德股份约59.10万股 减持股份",
                "features": {
                    "keywords": [
                        "Wellington Management",
                        "药明康德",
                        "减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-04-08",
                "original_text": "奥赛康(002755)事件点评：Q1业绩表现优异 麦芽酚铁胶囊成功获批临床有望快速上市",
                "features": {
                    "keywords": [
                        "奥赛康",
                        "Q1业绩",
                        "麦芽酚铁胶囊",
                        "临床"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-04-08",
                "original_text": "两市百元股数量达134只，医药生物行业占比最高",
                "features": {
                    "keywords": [
                        "百元股",
                        "医药生物"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-09",
                "original_text": "A股资金流向（4月9日）：新股上市首日遭爆炒，白马股再遭抛售",
                "features": {
                    "keywords": [
                        "A股",
                        "资金流向",
                        "新股",
                        "白马股"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-04-08",
                "original_text": "【异动股】药明康德(02359-HK)跌3.28%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "异动股",
                        "下跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-04-08",
                "original_text": "受益于国内创新药开发投入增加，CRO企业财报亮眼",
                "features": {
                    "keywords": [
                        "创新药",
                        "CRO",
                        "财报"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-04-08",
                "original_text": "A股融资融券日报：两融余额增加19.55亿元（4月8日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-08",
                "original_text": "74股获券商买入评级，美亚光电目标涨幅达79.94%",
                "features": {
                    "keywords": [
                        "券商评级",
                        "美亚光电",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-04-08",
                "original_text": "药明康德4月8日现2笔大宗交易",
                "features": {
                    "keywords": [
                        "药明康德",
                        "大宗交易"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}